ClinSV: clinical grade structural and copy number variant detection from whole genome sequencing data

被引:0
作者
Andre E. Minoche
Ben Lundie
Greg B. Peters
Thomas Ohnesorg
Mark Pinese
David M. Thomas
Andreas Zankl
Tony Roscioli
Nicole Schonrock
Sarah Kummerfeld
Leslie Burnett
Marcel E. Dinger
Mark J. Cowley
机构
[1] Kinghorn Centre for Clinical Genomics,Children’s Cancer Institute
[2] Garvan Institute of Medical Research,Sydney Medical School
[3] St Vincent’s Clinical School,Prince of Wales Clinical School
[4] Sydney Genome Diagnostics,Neuroscience Research Australia
[5] The Children’s Hospital at Westmead,undefined
[6] Genome.One,undefined
[7] University of New South Wales,undefined
[8] School of Women’s and Children’s Health,undefined
[9] The Kinghorn Cancer Centre and Cancer Division,undefined
[10] Garvan Institute of Medical Research,undefined
[11] Department of Clinical Genetics,undefined
[12] The Children’s Hospital at Westmead,undefined
[13] The University of Sydney,undefined
[14] NSW Health Pathology Randwick,undefined
[15] Centre for Clinical Genetics,undefined
[16] Sydney Children’s Hospital,undefined
[17] University of New South Wales,undefined
[18] University of New South Wales,undefined
[19] School of Biotechnology and Biomolecular Sciences,undefined
来源
Genome Medicine | / 13卷
关键词
Structural variation; Copy number variation; Whole genome sequencing; Microarray; Clinical genome; Rare disease;
D O I
暂无
中图分类号
学科分类号
摘要
Whole genome sequencing (WGS) has the potential to outperform clinical microarrays for the detection of structural variants (SV) including copy number variants (CNVs), but has been challenged by high false positive rates. Here we present ClinSV, a WGS based SV integration, annotation, prioritization, and visualization framework, which identified 99.8% of simulated pathogenic ClinVar CNVs > 10 kb and 11/11 pathogenic variants from matched microarrays. The false positive rate was low (1.5–4.5%) and reproducibility high (95–99%). In clinical practice, ClinSV identified reportable variants in 22 of 485 patients (4.7%) of which 35–63% were not detectable by current clinical microarray designs. ClinSV is available at https://github.com/KCCG/ClinSV.
引用
收藏
相关论文
共 275 条
  • [1] Chiang C(2017)The impact of structural variation on human gene expression Nat Genet 49 692-699
  • [2] Scott AJ(2014)The clinical significance of small copy number variants in neurodevelopmental disorders J Med Genet 51 677-688
  • [3] Davis JR(2013)The growing importance of CNVs: new insights for detection and clinical interpretation Front Genet 4 92-347
  • [4] Tsang EK(2014)Genome sequencing identifies major causes of severe intellectual disability Nature. 511 344-764
  • [5] Li X(2010)Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies Am J Hum Genet 86 749-11906
  • [6] Kim Y(2016)Deep sequencing of 10,000 human genomes Proc Natl Acad Sci 113 11901-85
  • [7] Asadollahi R(2016)Detecting copy number variation via next generation technology Curr Genet Med Rep 4 74-1590
  • [8] Oneda B(2016)Whole-genome sequencing overcomes pseudogene homology to diagnose autosomal dominant polycystic kidney disease Eur J Hum Genet EJHG 24 1584-81
  • [9] Joset P(2015)An integrated map of structural variation in 2,504 human genomes Nature. 526 75-712
  • [10] Azzarello-Burri S(2010)Origins and functional impact of copy number variation in the human genome Nature. 464 704-984